Crestline Management, L.P. 13F holdings, Q1 2025
Holdings as of March 31, 2025 · filings on SEC EDGAR · latest filing →
Crestline Management, L.P. disclosed 3 US equity positions worth $63.2m in its Q1 2025 13F filing. The largest position was DNLI at 89.5% of the reported book, followed by SANA and EGHT. Against the Q4 2024 filing, it opened 0 new positions, added to 0 and reduced 3 among the top 3 holdings.
What did Crestline Management, L.P. own in Q1 2025? Top 3 positions
| # | Stock | Sector | Weight | Value | Shares | Δ shares | vs Q4 2024 |
|---|---|---|---|---|---|---|---|
| 1 | DNLI DENALI THERAPEUTICS INC | Healthcare | 89.5% | $56.6m | 4,160,732 | -3% | reduced |
| 2 | SANA SANA BIOTECHNOLOGY INC | Healthcare | 7.4% | $4.7m | 2,790,937 | -2% | reduced |
| 3 | EGHT 8X8 INC NEW | Technology | 3.1% | $2.0m | 990,580 | -1% | reduced |
Weights are shares of the reported long US equity book (options excluded). Values are as filed, normalised to whole dollars. Share changes compare against the immediately preceding filing only.